Bala Medicherla Email Address

Director, BioAnalytics

Paragon Bioservices is a private-equity backed contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of biopharmaceuticals. The company provides research services, process development and cGMP manufacturing. Paragon functions as a translational bridge from the research bench through manufacturing of APIs and finished drug product for Phase I/II clinical trials. Paragon s aim is to build strong client partnerships for development and manufacturing, focusing on transformative technologies, including oncology immunotherapies (CAR-T cell therapies and oncolytic viruses), new generation vaccines (VLPs) and gene therapies (AAV). Paragon s cGMP facilities include microbial and mammalian suites, aseptic fill-finish and fully-segregated virus facilities.

Experienced assay development professional with 10 years’ experience in biotech CRO & CDMO industry focused on assisting over 30 clients in the AAV Gene Therapy space, successfully driving molecular, cellular, and immune assay delivery from Phase 1 through Phase 3 and commercial production. Result-driven team manager to 23 scientists performing assay design, development, qualification, and validation of assays for client AAV molecules.